GlycoMimetics Inc (GLYC.OQ)
GLYC.OQ on NASDAQ Stock Exchange Global Market
17.72USD
23 Apr 2018
17.72USD
23 Apr 2018
Change (% chg)
$0.07 (+0.40%)
$0.07 (+0.40%)
Prev Close
$17.65
$17.65
Open
$17.71
$17.71
Day's High
$17.93
$17.93
Day's Low
$17.38
$17.38
Volume
120,643
120,643
Avg. Vol
259,070
259,070
52-wk High
$26.05
$26.05
52-wk Low
$3.83
$3.83
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 0.00 | -0.271 |
| Sep '17 | 0.00 | -0.243 | |
| Jun '17 | 0.00 | -0.299 | |
| Mar '17 | 0.00 | -0.338 | |
| FY 2016 | Dec '16 | 0.00 | -0.360 |
| Sep '16 | 0.02 | -0.341 | |
| Jun '16 | 0.00 | -0.408 | |
| Mar '16 | 0.00 | -0.396 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Sep-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 4 | 20.52 | 50.00 | 0.00 | 46.00 |
| Year Ending Dec-19 | 4 | 12.50 | 36.00 | 0.00 | 31.18 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 4 | -0.31 | -0.27 | -0.34 | -- |
| Quarter Ending Sep-18 | 4 | -0.34 | -0.27 | -0.40 | -- |
| Year Ending Dec-18 | 5 | -1.01 | 0.33 | -1.50 | -0.29 |
| Year Ending Dec-19 | 4 | -1.48 | -1.12 | -1.87 | -0.55 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 185.04 | 32.78 | |
| P/E High - Last 5 Yrs. | -- | 284.68 | 45.94 | |
| P/E Low - Last 5 Yrs. | -- | 95.75 | 24.95 | |
| Beta | 3.40 | 0.75 | 0.80 | |
| Price to Sales (TTM) | -- | 136.40 | 7.08 | |
| Price to Book (MRQ) | 5.09 | 19.34 | 5.00 | |
| Price to Tangible Book (MRQ) | 6.27 | 24.06 | 6.75 | |
| Price to Cash Flow (TTM) | -- | 122.96 | 25.60 | |
| % Owned Institutions | 76.24 | 11.18 | 2.21 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.29 | 1.55 | |
| Dividend Yield - 5 Year Avg | -- | 0.20 | 0.74 | |
| Dividend 5 Year Growth Rate | -- | 1.94 | 3.92 | |
| Payout Ratio(TTM) | -- | 9.18 | 20.28 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 103.99 | 9.00 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -100.00 | 80.63 | 10.85 | |
| Sales - 5 Yr. Growth Rate | -- | 33.87 | 8.21 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 24.75 | -66.82 | 22.25 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 23.54 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 47.44 | 10.24 | |
| Capital Spending - 5 Yr. Growth Rate | -1.44 | 45.48 | 10.39 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.63 | 2.53 |
| Current Ratio (MRQ) | 15.56 | 5.97 | 3.62 |
| LT Debt to Equity (MRQ) | 0.00 | 23.32 | 11.28 |
| Total Debt to Equity (MRQ) | 0.00 | 25.75 | 13.94 |
| Interest Coverage (TTM) | -- | -181.71 | 30.08 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 36.28 | 53.98 | |
| Gross Margin - 5 Yr. Avg. | -- | 55.36 | 52.10 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -254.26 | -149.35 | 15.94 | |
| Operating Margin (TTM) | -- | -564.83 | 4.32 | |
| Operating Margin - 5 Yr. Avg. | -256.66 | -161.27 | 11.31 | |
| Pre-Tax Margin (TTM) | -- | -537.64 | 4.97 | |
| Pre-Tax Margin - 5 Yr. Avg. | -254.64 | -168.32 | 11.62 | |
| Net Profit Margin (TTM) | -- | -526.60 | 1.58 | |
| Net Profit Margin - 5 Yr. Avg. | -254.64 | -168.70 | 7.94 | |
| Effective Tax Rate (TTM) | -- | -0.44 | 31.27 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.13 | 24.27 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 0 | 23,918,133 | 819,537,692 | |
| Net Income/Employee (TTM) | -832,027 | 754,796 | 96,346,718 | |
| Receivable Turnover (TTM) | -- | 6.24 | 5.57 | |
| Inventory Turnover (TTM) | -- | 2.37 | 3.45 | |
| Asset Turnover (TTM) | 0.00 | 0.40 | 0.89 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -38.93 | -0.77 | 10.55 | |
| Return on Assets - 5 Yr. Avg. | -43.89 | 0.69 | 11.58 | |
| Return on Investment (TTM) | -42.54 | -0.74 | 13.21 | |
| Return on Investment - 5 Yr. Avg. | -50.51 | 4.20 | 14.99 | |
| Return on Equity (TTM) | -42.94 | -2.80 | 15.01 | |
| Return on Equity - 5 Yr. Avg. | -50.93 | -0.05 | 16.27 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -100.00 | -- | -- |
| EPS (TTM) % | 24.34 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for GlycoMimetics Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-GlycoMimetics Announces Proposed Public Offering Of Common Stock
- BRIEF-Glycomimetics Reports Q4 Loss Per Share $0.27
- BRIEF-Glycomimetics Enters Agreement With Hovon To Initiate Study Startup Activities For Planned Clinical Trial Of GMI-1271 And Decitabine
- BRIEF-GlycoMimetics qtrly loss per share $0.24
Institutional Holders
| % Shares Owned: | 76.24% |
| # of Holders: | 111 |
| Total Shares Held: | 32,397,376 |
| 3 Mo. Net Change: | -25,565 |
| # New Positions: | 3 |
| # Closed Positions: | 3 |
| # Increased Positions: | 7 |
| # Reduced Positions: | 9 |
| # Net Buyers: | -2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.